Intranasal Nystatin Therapy in Patients with Chronic Illness Associated with Mold and Mycotoxins

Treatment observations in which patients intolerant to AMB were treated with intranasal nystatin (NYS) found very promising improvements with this agent as well and found that the urine mycotoxin levels decreased substantially in patients that improved on therapy.